Last reviewed · How we verify

Intravenous magnesium sulphate

Saima Khatoon · FDA-approved active Small molecule Quality 5/100

Intravenous magnesium sulphate is a Small molecule drug developed by Saima Khatoon. It is currently FDA-approved. Also known as: IV MgSO4, IVM (intravenous magnesium).

At a glance

Generic nameIntravenous magnesium sulphate
Also known asIV MgSO4, IVM (intravenous magnesium)
SponsorSaima Khatoon
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Intravenous magnesium sulphate

What is Intravenous magnesium sulphate?

Intravenous magnesium sulphate is a Small molecule drug developed by Saima Khatoon.

Who makes Intravenous magnesium sulphate?

Intravenous magnesium sulphate is developed and marketed by Saima Khatoon (see full Saima Khatoon pipeline at /company/saima-khatoon).

Is Intravenous magnesium sulphate also known as anything else?

Intravenous magnesium sulphate is also known as IV MgSO4, IVM (intravenous magnesium).

What development phase is Intravenous magnesium sulphate in?

Intravenous magnesium sulphate is FDA-approved (marketed).

Related